Global Skin Patch Market By Product Type (Fentanyl, Nicotine) And By End-Users/Application (Hospital Pharmacies, Retail Pharmacies) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Skin Patch market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Skin Patch market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Skin Patch industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Skin Patch ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Skin Patch market.

The following manufacturers are covered in this report:
  • GSK
  • Teikoku Seiyaku
  • Johnson & Johnson
  • Novartis AG
  • Mylan N.V.
  • Bayer
  • Lingrui
  • Sanofi
  • Teva Pharmaceutical Industries
  • Luye Pharma Group
  • Hisamitsu Pharmaceutical
  • Mundipharma International
  • Purdue Pharma

The report estimates on the Skin Patch market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Skin Patch market report consist of all leading industry players, Skin Patch business sections, company profile, revenue supply by Skin Patch industry sections, global Skin Patch market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Skin Patch market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Skin Patch market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Skin Patch market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Skin Patch market.

Report Opportunity: Global Skin Patch Market

This report delivers an analytical examination of the Skin Patch market summarized in broad sections such as
  1. Skin Patch Market Summary
  2. Key Commercial Growths in the Skin Patch Industry
  3. Market Dynamics Affecting the Skin Patch Industry
  4. Important Market Trends and Future Development Scenario of the Skin Patch Market
  5. Skin Patch Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Skin Patch Industry
  7. Positioning of Main Market Players in the Skin Patch Industry
  8. Skin Patch Market Revenue and Forecast, by Application, 2018 - 2028
  9. Skin Patch Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Skin Patch Market Revenue and Forecast, by Geography, 2018 - 2028
Skin Patch Market Segmentation:

The report provides detailed examination of the Skin Patch market on the basis of various segments such as type, application and end-use industry. The Skin Patch market is segmented as follows:

Skin Patch Market, by Type:
  • Fentanyl
  • Nicotine
  • Clonidine
  • Buprenorphine
Skin Patch Market, by Application:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Geographic Coverage

The report on the Skin Patch market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Skin Patch Market Revenue and Forecast
  • U.S.
  • Canada
Europe Skin Patch Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Skin Patch Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Skin Patch Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Skin Patch Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Skin Patch Market Snapshot
          2.1.1. Global Skin Patch Market By Type,2019
               2.1.1.1.Fentanyl
               2.1.1.2.Nicotine
               2.1.1.3.Clonidine
               2.1.1.4.Buprenorphine
          2.1.2. Global Skin Patch Market By Application,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Skin Patch Market By End-use,2019
          2.1.4. Global Skin Patch Market By Geography,2019

3. Global Skin Patch Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Skin Patch Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Skin Patch Market Size (US$), By Type, 2018 – 2028

5. Global Skin Patch Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Skin Patch Market Size (US$), By Application, 2018 – 2028

6. Global Skin Patch Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Skin Patch Market Size (US$), By End-use, 2018 – 2028

7. Global Skin Patch Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Skin Patch Market Analysis, 2018 – 2028 
          7.2.1. North America Skin Patch Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Skin Patch Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Skin Patch Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Skin Patch Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Skin Patch Market Analysis, 2018 – 2028 
          7.3.1.  Europe Skin Patch Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Skin Patch Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Skin Patch Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Skin Patch Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Skin Patch Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Skin Patch Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Skin Patch Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Skin Patch Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Skin Patch Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Skin Patch Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Skin Patch Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Skin Patch Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Skin Patch Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Skin Patch Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Skin Patch Market Analysis, 2018 – 2028 
          7.6.1.  MEA Skin Patch Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Skin Patch Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Skin Patch Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Skin Patch Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Skin Patch Providers
        8.4.1 GSK
                8.1.1 Business Description
                8.1.2 GSK Geographic Operations
                8.1.3 GSK Financial Information
                8.1.4 GSK Product Positions/Portfolio
                8.1.5 GSK Key Developments
        8.4.2 Teikoku Seiyaku
                8.2.1 Business Description
                8.2.2 Teikoku Seiyaku Geographic Operations
                8.2.3 Teikoku Seiyaku Financial Information
                8.2.4 Teikoku Seiyaku Product Positions/Portfolio
                8.2.5 Teikoku Seiyaku Key Developments
        8.4.3 Johnson & Johnson
                8.3.1 Business Description
                8.3.2 Johnson & Johnson Geographic Operations
                8.3.3 Johnson & Johnson Financial Information
                8.3.4 Johnson & Johnson Product Positions/Portfolio
                8.3.5 Johnson & Johnson Key Developments
        8.4.4 Novartis AG
                8.4.1 Business Description
                8.4.2 Novartis AG Geographic Operations
                8.4.3 Novartis AG Financial Information
                8.4.4 Novartis AG Product Positions/Portfolio
                8.4.5 Novartis AG Key Developments
        8.4.5 Mylan N.V.
                8.5.1 Business Description
                8.5.2 Mylan N.V. Geographic Operations
                8.5.3 Mylan N.V. Financial Information
                8.5.4 Mylan N.V. Product Positions/Portfolio
                8.5.5 Mylan N.V. Key Developments
        8.4.6 Bayer
                8.6.1 Business Description
                8.6.2 Bayer Geographic Operations
                8.6.3 Bayer Financial Information
                8.6.4 Bayer Product Positions/Portfolio
                8.6.5 Bayer Key Developments
        8.4.7 Lingrui
                8.7.1 Business Description
                8.7.2 Lingrui Geographic Operations
                8.7.3 Lingrui Financial Information
                8.7.4 Lingrui Product Positions/Portfolio
                8.7.5 Lingrui Key Developments
        8.4.8 Sanofi
                8.8.1 Business Description
                8.8.2 Sanofi Geographic Operations
                8.8.3 Sanofi Financial Information
                8.8.4 Sanofi Product Positions/Portfolio
                8.8.5 Sanofi Key Developments
        8.4.9 Teva Pharmaceutical Industries
                8.9.1 Business Description
                8.9.2 Teva Pharmaceutical Industries Geographic Operations
                8.9.3 Teva Pharmaceutical Industries Financial Information
                8.9.4 Teva Pharmaceutical Industries Product Positions/Portfolio
                8.9.5 Teva Pharmaceutical Industries Key Developments
        8.4.10 Luye Pharma Group
                8.10.1 Business Description
                8.10.2 Luye Pharma Group Geographic Operations
                8.10.3 Luye Pharma Group Financial Information
                8.10.4 Luye Pharma Group Product Positions/Portfolio
                8.10.5 Luye Pharma Group Key Developments
        8.4.11 Hisamitsu Pharmaceutical
                8.11.1 Business Description
                8.11.2 Hisamitsu Pharmaceutical Geographic Operations
                8.11.3 Hisamitsu Pharmaceutical Financial Information
                8.11.4 Hisamitsu Pharmaceutical Product Positions/Portfolio
                8.11.5 Hisamitsu Pharmaceutical Key Developments
        8.4.12 Mundipharma International
                8.12.1 Business Description
                8.12.2 Mundipharma International Geographic Operations
                8.12.3 Mundipharma International Financial Information
                8.12.4 Mundipharma International Product Positions/Portfolio
                8.12.5 Mundipharma International Key Developments
        8.4.13 Purdue Pharma
                8.13.1 Business Description
                8.13.2 Purdue Pharma Geographic Operations
                8.13.3 Purdue Pharma Financial Information
                8.13.4 Purdue Pharma Product Positions/Portfolio
                8.13.5 Purdue Pharma Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Skin Patch Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Skin Patch Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Skin Patch Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Skin Patch Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Skin Patch Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Skin Patch Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Skin Patch Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Skin Patch Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Skin Patch Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Skin Patch Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Skin Patch Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Skin Patch Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Skin Patch Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Skin Patch Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Skin Patch Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Skin Patch Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Skin Patch: Market Segmentation 
FIG. 2 Global Skin Patch Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Skin Patch Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Skin Patch Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Skin Patch Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Skin Patch Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Skin Patch Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Skin Patch Providers, 2019
FIG. 11 Global Skin Patch Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Skin Patch Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Skin Patch Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Skin Patch Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Skin Patch Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Skin Patch Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Skin Patch Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Skin Patch Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Skin Patch market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1942

1348

OUR CLIENT